Video

Alex Molasiotis, RN, PhD, on the Management on Breathlessness

Alex Molasiotis, RN, PhD, discusses the results of a pilot feasibility study looking at inspiratory muscle training for the management of breathlessness in patients with lung cancer.

Alex Molasiotis, RN, PhD, professor, Head of School, School of Nursing, The Hong Kong Polytechnic University, discusses the results of a pilot feasibility study looking at inspiratory muscle training for the management of breathlessness in patients with lung cancer.

This study found that inspiratory muscle training is feasible: it was helpful to manage distress, improve dyspnea scores, and help patients to feel in control of their disease. Patients also reported being able to take more walks and walk longer.

Now, Molasiotis says, inspiratory muscle training must be looked at in a larger trial.

<<<

View more from the 2014 MASCC/ISOO Symposium

Related Videos
J. Bradley Elder, MD
Rimas V. Lukas, MD
Paolo Caimi, MD
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Haley M. Hill, PA-C, discusses the role of multidisciplinary management in NRG1-positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses preliminary data for zenocutuzumab in NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.